-
p wave
–Atrial systole
- –Signal from SA node spreads through
- atria and depolarization begins
- –Correlates with phase 0 of
- myocardial action potential
-
QRS complex
- –Firing of AV node and ventricular
- depolarization
- –Atrial repolarization and
- diastole
- –Correlates with phase 1 of
- myocardial action potential
-
S-T segment
–Ventricular systole
–Contraction and ejection of blood
- –Correlates with phase 2 of
- myocardial action potential
-
T wave
–Ventricular repolarization
- –Immediately before ventricular
- diastole
- –Correlates with phase 3 of
- myocardial action potential
-
-
Qt prolongation
Genetic or acquired
Caused by drugs and electrolyte abnormalities
- –Antiarrhythmics, antipsychotics, antibiotics,
- methadone
–Hypokalemia, hypomagnesemia
-
Angioplasty
- Procedure to open blocked or narrowed coronary arteries
- Done during the left cardiac catheterization
- Balloon angioplasty alone or with stent placement
-
CABG
Coronary artery bypass grafting
nOpen heart surgery
nGrafts harvested from legs, chest, or arms
nGrafts are used as a “detour” around the blocked portion of the coronary artery
-
COAGULATION FACTORS
1. vitamin k dependent
2. thrombin sensitive
- 1. - 2, 7, 9, 10
- 2. - 5, 8, 13, fibrinogen
-
anticoagulants
- —Prevent/treat venous thrombi
- **prevents clots from getting bigger
- VTE --> PE, DVT
composed mainly of fibrin and RBCs = red clots
-
antiplatelets
- prevent/treat arterial thrombi
- - MI, stroke, limb gangrene
composed mainly of platelets = white clots
-
anticoagulant drugs
- vitamin k antagonists (warfarin)
- heparin
- factor Xa inhibitors
- direct thrombin inhibitors
-
antiplatelet drug therapy
- asparin
- ADP inhibitors
- - thienopyridines (clopidogrel)
- - cyclopentyltriazolopyrimidine (ticagrelor)
- Phosphodiesterase inhibitors
- glycoprotein 2b/3a inhibitors
-
Fibrinolytics - thrombolytics
Dissolving existing clots
use: plasminogen activators
-
|
|